PICKERING, ON, June 10, 2025 – MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) (“MTL” or the “Company”) is pleased to announce that it has met the requirements for an upgrade from the OTCQB^® Venture Market to the OTCQX^® Best Market (the “OTCQX Market” or “OTCQX”). Trading of MTL Cannabis Corp. shares will begin today on the OTCQX under the ticker symbol “MTLNF”.

The OTCQX Market, considered the premier tier of the U.S. OTC Markets, is tailored for established U.S. and international companies that prioritize their investors. Companies trading on the OTCQX are expected to benefit from increased visibility and easier access for U.S. investors due to the market’s stringent financial and governance requirements.

“We are excited about moving up to the OTCQX market. We believe that OTCQX will serve as a valuable platform to enhance our exposure to U.S. investors,” stated Michael Perron, CEO of MTL Cannabis Corp.

The Company’s common shares will continue to be listed on the Canadian Securities Exchange in Canada under the symbol “MTLC”.

About MTL Cannabis Corp.

MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. (“MTL Cannabis”), a licensed producer with a 57,000 sq ft indoor cultivation facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer based in Pickering, Ontario, which operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec, specializing in top-tier indoor cannabis cultivation within its 64,000 sq. ft. production facility; and Canada House Clinics Inc., which manages clinics across Canada, collaborating with primary care teams to offer specialized cannabinoid therapy services for patients with various medical conditions.

As a company focused on high-quality flower and designed for the modern market, MTL Cannabis employs advanced hydroponic growing techniques alongside meticulous handcrafting methods to create exceptional products for a broad audience. MTL Cannabis concentrates on premium cannabis products, including dried flower, pre-rolls, and hash lines marketed under the “MTL Cannabis”, “Low Key by MTL” and “R’belle” brands for the Canadian market through nine distribution agreements with provincial cannabis distributors. MTL Cannabis has also established multiple export channels for bulk and unbranded GACP-quality cannabis.

MTL’s ambition is for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada, and for Canada House Clinics to become the foremost Canadian provider of medical cannabis clinic services.

For additional details, please visit or review the Company’s public filings at .

Cautionary Statement Regarding Forward-Looking Information.
This press release includes forward-looking statements concerning the Company’s clinic, production, and technology operations, its future strategies, markets, objectives, goals, intentions, beliefs, expectations, and estimates. These statements can often be identified by terms such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective”, and “continue” (or their negative forms) and similar expressions. While the Company believes these forward-looking statements are reasonable, they involve inherent risks and uncertainties, and readers should not unduly rely on them. These statements are based on certain material factors or assumptions, and actual results may significantly differ from those implied or expressed. Key assumptions used in these forward-looking statements include regulations related to cannabis use under the Cannabis Act (Canada); the Company’s liquidity and capital resources, including access to additional funding to support its operations and repay debt; the competitive landscape; the ability to adapt products and services to market changes; the ability to attract and retain key personnel; the successful execution of strategic plans; the ongoing integration of business units, expansion activities at all operating sites; and the leveraging of operational cash flow to accelerate growth and strengthen the Company’s balance sheet. Further details on material factors that could cause actual results to vary materially from expectations, as well as the assumptions used in formulating forward-looking statements, can be found in the Company’s Listing Statement dated August 14, 2023, and its most recent annual and interim Management’s Discussion and Analysis under “Risk and Uncertainties,” along with other public filings with Canadian securities regulators. The Company disclaims any intention or obligation to update or revise any forward-looking statements in this document, whether due to new information, future events, or other factors, except as required by law.

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE MTL Cannabis Corp.

“`